Ireland
--:--IST
Latest
Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing
Clinical Trials in France / NCT02869581
Recruiting Observational

Institut Paoli-Calmettes Pancreatic Neoplasms Database

NCT02869581 · tracked via the Priya Life Science France tracker
Sponsor
Institut Paoli-Calmettes
Phase
Observational
Started
2000-01
Last updated
2016-08-17

Condition(s) studied

Pancreatic Neoplasms

Investigational drug(s) / intervention(s)

Data collection

Study summary

Database of Institut Paoli Calmettes diagnosed with Pancreatic neoplasms

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patient with a diagnosis of Pancreatic neoplasm Exclusion Criteria: * Patient with a diagnosis of cholangiocarcinoma

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institut Paoli Calmettes Marseille Bouches du Rhone Recruiting

More Institut Paoli-Calmettes trials in France

Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma Recruiting
Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients Recruiting
Pancreatic Surgical Database Recruiting
Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis Recruiting
Institut Paoli Calmettes Multiple Myeloma Database Recruiting

Other trials for the same condition

Pancreatic Surgical Database Recruiting
Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02869581 on ClinicalTrials.gov ↗ ← All trials in France